Inhibition of two stage renal carcinogenesis, oxidative damage and hyperproliterative response by Nigella sativa

European Journal of Cancer Prevention

Volumn 14, Issue 2, 2005, Pages 159-168

  Khan, N ^a   Sultana, S ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Chemoprevention; Ferric nitrilotriacetate; Nigella sativa; Oxidative stress; Renal carcinogenesis

Indexed keywords

CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; HYDROGEN PEROXIDE; NIGELLA SATIVA EXTRACT; NITRILOTRIACETATE IRON; ORNITHINE DECARBOXYLASE; POTASSIUM BROMATE; THYMIDINE; TRITIUM; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLACK CUMIN; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA SYNTHESIS; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; FEMALE; KIDNEY CARCINOMA; LIPID PEROXIDATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CARCINOGENS; CARCINOMA, RENAL CELL; CELL PROLIFERATION; CHEMOPREVENTION; FEMALE; FERRIC COMPOUNDS; KIDNEY NEOPLASMS; NIGELLA SATIVA; NITRILOTRIACETIC ACID; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 17144404169     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200504000-00012     Document Type: Article

References (52)

1. Ahmed S, Rahman A, Mathur M, Athar M, Sultana S (2001). Antitumor promoting activity of Asteracantha long/folia against experimental hepatocarcinogenesis in rats. Food Chem Toxicol 39: 19-28.
2. Ali BH, Blunden G (2003). Pharmacological and toxicological properties of Nigella saliva. Phytother Res 17: 299-305.
3. Al-Shabanah OA, Badary OA, Nagi MN, et al. (1998). Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its anti-tumor activity. J Exp Clin Cancer Res 17: 193-198.
4. Anderson RL, Bishop WE, Campbell RL (1985). A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit Rev Toxicol 15: 1-102.
5. Antonio A, Souza A, Brito RM (1988). Oral anti-inflammatory and anti-ulcerogenic activities of a hydroalcoholic extract and partitioned fraction of Turnera ulmifolia (Turneaceae). J Ethnopharmacol 61: 215-228.
6. Athar M, Iqbal M (1998). Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rats: implications for the involvement of oxidative stress. Carcinogenesis 19: 1133-1139.
7. Athar M, Sharma SD, Iqbal M, et al. (1996). Coordination of copper polyamines complex with immidiozoles potentiates its superoxide dismutase mimicking activity and abolishes its interactions with albumin. Biochem Mol Biol Int 39: 813-821.
8. Awai M, Narasaki M, Yamanoi Y, Seno S (1979). Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 95: 663-672.
9. Badary OA, Nagi MN, Al-Shabanah OA, et al. (1997). Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol 75: 1356-1361.
10. Benson AM, Hunkalar MJ, Talalay P (1980). Increase of NADPH, quinone reductase activity by dietary antioxidant: Possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77: 5116-5220.
11. Block G (1992). A role for antioxidants in reducing cancer risk. Nutr Rev 50: 207-213.
12. Carlberg I, Mannervik B (1975). Glutathione level in rat brain. J Biol Chem 250: 4575-4580.
13. Chopra RN, Nayar SL, Chopra IC (1996). Glossary of Indian Medicinal Plants. National Institute of Science Communication: New Delhi, pp. 176-177.
14. Claiborne A (1985). Catalase activity. In: Greenwald RA (ed.), CRC Handbook of Methods in Oxygen Radical Research. Boca Raton: CRC Press, pp. 283-284.
15. De Flora S, Ramel C (1988). Mechanism of inhibition of mutagenesis and carcinogenesis: Classification and Overview. Mutat Res 202: 285-306.
16. Didry N, Duberwil L, Tratin F, Pinkas M (1988). Antimicrobial activity of aerial parts of Drossera pelitata Smith on oral bacteria. J Ethnopharmacol 60: 215-228.
17. El-Dakhakhny M, Madi NJ, Lembert N, Ammon HP (2002). Nigella saliva oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol 81: 161-164.
18. Giles KW, Myers A (1965). An improved diphenyl method for the estimation of deoxyribonucleic acid. Nature 206: 93.
19. Habig WH, Pabst MJ, Jakoby WB (1974). Glutathione-S-transferases: The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
20. Hamazaki S, Okada S, Ebina Y, Midorikawa O (1985). Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol Appl Pharmacol 77: 267-274.
21. Hamazaki S, Okada S, Li JL (1989). Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate. Arch Biochem Biophys 272: 10-17.
22. Haq A, Abdullatif M (1995). Nigella saliva: Effect on human lymphocytes and polymorphonuclear leukocyte phagocytic activity. Immunopharmacology 30: 147-155.
23. Hare RS (1950). Endogenous creatinine in serum and urine. Proc Soc Exp Biol Med 74: 148.
24. Houghton PJ, Zarka R, Delas HB, Hoult JR (1995). Fixed oil of Nigella saliva and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61: 33-36.
25. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974). Bromobenzene induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11: 151.
26. Kanter MW (1975). Clinical Chemistry. USA: The Bobber Merill Company Inc, pp. 80.
27. Kapoor LD (1990). CRC Handbook of Ayurvedic Medicinal Plants. Boca Raton, Florida: CRC Press, p. 187.
28. Khan MA (1999). Chemical composition and medicinal properties of Nigella sativa. Inflammopharmacology 7: 15-35.
29. Khan N, Sharma S, Alam A, Saleem S, Sultana S (2001). Tephrosia purpurea ameliorates N-diethylnitrosamine and potassium bromate-mediated renal oxidative stress and toxicity in Wistar rats. Pharmacol Toxicol 88: 294-299.
30. Khan N, Sharma S, Sultana S (2003). Nigella sativa ameliorates potassium bromate induced early events of carcinogenesis: diminution of oxidative stress. Hum Exp Toxicol 22: 193-203.
31. Khan N, Sharma S, Sultana S (2004). Attenuation of potassium bromate-induced nephrotoxicity by coumarin (1,2-benzopyrone) in Wistar rats: chemoprevention against free radical-mediated renal oxidative stress and tumor promotion response. Redox Rep 9: 19-28.
32. Klein CB, Frenkel K, Costa M (1991). The role of oxidative processes in metal carcinogenesis. Chem Res Toxicol 4: 592-604.
33. Lowry OH, Rosebrough NJ, Fan A, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
34. Mohandas M, Marshal JJ, Duggin GG, Horvath JS, Tiller D (1984). Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Cancer Res 44: 5086-5091.
35. Nagi MN, Alam K, Badary OA, et al. (1999). Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 47: 153-159.
36. Norton SA (1998). Herbal medicines in Hawaii from tradition to convention. Hawaii Med J 57: 382-386.
37. O'Brien TG, Simsiman RC, Boutwell RK (1975). Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor promoting agents. Cancer Res 35: 1662-1670.
38. Okada S, Minamiyama Y, Hamazaki S, Toyokuni S, Sotomatsu A (1993). Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse renal proximal tubules. Arch Biochem Biophys 301: 138-142.
39. Orlowski M, Meister A (1973). γ-glutamyl cyclotransferase distribution, isozymic forms and specificity. J Biol Chem 248: 2836-2844.
40. Pegg AE, Shantz LM, Colemn CS (1995). Ornithine decarboxylase as a target for chemoprevention. J Biol Chem 22: 132-138.
41. 2 production by chemically elicited peritoneal macrophages-induction by multiple non-phagocytic stimulus. Cell Immunol 59: 301-308.
42. Pitot HC (1993). The molecular biology of carcinogenesis. Cancer 72: 962-970.
43. Rogers AE (1982.) Nitrosamines. In: Newberne PM (ed.), Trace Substances and Health, A Handbook Part 2; New York: Marcel Deekker, pp. 47-80.
44. Shantz LM, Pegg AE (1994). Overproduction of ornithine decarboxylase caused by relief of translational repression in neoplastic transformation. Cancer Res 54: 2313-2316.
45. Smart RC, Huang MT, Conney AH (1986). Sn 1,2-diacylglycerols mimic the effects of TPA in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis 7: 1865-1870.
46. Surh YJ (1999). Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 428: 305-327.
47. Takruri HRH, Dameh MAF (1998). Study of the nutritional value of black cumin seeds (Nigella saliva L). J Sci Food Agriculture 76: 404-410.
48. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y (1995). Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82-83: 173-179.
49. Uedo N, Tatsuta M, Iishi H, et al. (1999). Inhibition by D-limonene of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett 137: 131-136.
50. Worthern DR, Ghosheh OA (1998). The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella saliva L. Anticancer Res 18: 1527-1532.
51. Wright JR, Colby HD, Miles PR (1981). Cytosolic factors that affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys 206: 296-304.
52. Zaheer N, Tiwari KK, Krishnan PS (1965). Exposure and solubilization of hepatic mitochondrial shunt dehydrogenases. Arch Biochem Biophys 109: 646-648.